baber/WOPTO huggingface dataset:
Patent CA-2695370-A1 (CA)
Inventor: PARINS DAVID J
IPC: A61M25/00
Filed: 2008-07-31
Abstract: An intracorporeal device includes a shaft having a proximal section including a first elongate member and a distal section including a tubular member and a second elongate member. A proximal region of the tubular member is attached to the distal region of the first elongate member. The second elongate member is disposed within the lumen of the tubular member, and a proximal region of the second elongate member is attached to the proximal region of the elongate tubular member. As such, in some embodiments, the tubular member can function both as a member joining the first and second elongate members, and as a structural element in the distal section of the shaft providing for desired flexibility, torqueability, and/or pushability characteristics. The lateral flexibility of the tubular member can be increased by including less material in the tubular member, while maintaining a good degree to torqueability and/or pushability characteristics. For example, the tubular member can include a plurality of apertures in it.
Patent CA-2698288-A1 (CA)
Inventor: HAGEN RAINER
IPC: C08G63/08
Filed: 2008-08-25
Abstract: The present invention relates to a device for separating a biodegradable, intermolecular cyclic diester of an alpha-hydroxycarboxylic acid from material mixtures which contain in addition the alpha--hydroxycarboxylic acid of the diester corresponding thereto. In particular, the diester is thereby dilactide and the acid lactic acid.  Furthermore, the present invention relates to a method for separating dilactide from material mixtures, which is based on a modified, distillative method. In addition, the present invention describes a polymerisation device, in particular for preparing polylactide. Likewise, purposes of use of both the devices and of the method are indicated.
Patent CA-2700030-A1 (CA)
Title: Touchpoint customization system
Inventor: ROYTMAN ANATOLY
IPC: G06Q30/00
Filed: 2010-04-15
Abstract: A system for touchpoint content action customization at a current touchpoint to achieve a business objective includes a user touchpoint data capture unit and a content action optimization engine. The content action optimization engine is configured to select a plurality of candidate content actions for the current touchpoint based on content action metadata, to determine an observed percentage of success for an observed user behavior for each of the plurality of candidate content actions based on the user group to which the user belongs, and to determine a customized content action of the plurality of candidate content actions to implement at the current touchpoint to achieve the business objective that has the highest observed percentage of success.
Patent CA-2700679-A1 (CA)
Title: Novel crystal form of 5-hydroxy-1-methylhydantoin
Inventor: OKAMOTO KAORU
IPC: C07D233/72
Filed: 2003-04-09
Abstract: The present invention is directed to a process for producing 5-hydroxy-1-methylimidazolidin-2,4-dione by hydrolyzing a brominated product of 1-methylhydantoin. The 5-hydroxy-1-methylimidazolidin-2,4-dione is used in the preparation of novel II-form crystals of 5-hydroxy-1-methylhydantoin.  Conventional I-form crystals of 5-hydroxy-1-methylhydantoin contain, remaining therein in a considerable amount, the organic solvent used in a purification step. In contrast, in II-form crystals, the amount of the organic solvent remaining therein is smaller than the detection limit. Namely, the II-form crystals contain substantially no residual organic solvent. The novel II-form crystals of 5-hydroxy-1-methylhydantoin obtained through recrystallization from water not only contain substantially no residual organic solvent, but also have a high bulk density and are hence advantageous for pharmaceutical preparation. They further have properties advantageous for production, such as low adhesion. The crystals are significantly useful as a material for medicines required to have high safety, such as drugs for renal insufficiency.
Patent CA-2701490-A1 (CA)
Inventor: BROOKS JEFFREY S
IPC: A61F5/00
Filed: 2008-10-03
Abstract: A body pad for application to the skin for treating an ailment. The pad includes a pad body, a recess in the pad body extending from the outer surface of the pad body toward the inner surface a distance which is less than an overall thickness of the body, and a thin, flexible wall at a bottom of the recess. The wall is adapted to deform outwardly into the recess to provide a cavity between the pad body and the skin for holding a volume of medication which has been pre-applied to the skin. Other pad features are disclosed.
Patent CA-2702079-A1 (CA)
Title: Voice-controlled clinical information dashboard
Inventor: NENOV VALERIY I
IPC: A61B5/00
Filed: 2008-10-08
Abstract: A method provides a display area of a computer system for displaying a set of data. The data includes clinical data for one or more medical patients. The method provides multiple controls for performing multiple functions. The method provides an audio interface for controlling at least one of the controls through audio commands.
Patent CA-2702597-A1 (CA)
Inventor: MIDDLEDITCH DAVE
IPC: B02C23/14
Filed: 2010-05-04
Abstract: A crushing apparatus for crushing a material including a first crusher for crushing the material into a first output; a first conveyor for transporting the first output; a first screen for separating the first output conveyed by the first conveyor into a first screened material and a second screened material; a second crusher for crushing the second screened material into a second output; a second conveyor for transporting the second output and the first screened material that are respectively received from the second crusher and the first screen; and a second screen for separating the second output and the first screen material conveyed by the second conveyor into a product material and a third screened material;  wherein the third screened material is received by the first conveyor.
Patent CA-2703212-A1 (CA)
Title: Discriminating web material dispenser
Inventor: PELLAND MIKE
IPC: B65H75/02
Filed: 2008-10-22
Abstract: An automatic product dispenser determines if the roll loaded into the dispenser is approved for use with the dispenser.  The core of a roll contains a feature that alters an electromagnetic field created proximate the core. The alteration of the electromagnetic field may then be used to determine if the core, and thus the roll, is usable with the dispenser. The feature is designed such that it is damaged once product is completely dispensed from the roll thereby preventing replenishment and reuse of a spent roll.
Patent CA-2703752-A1 (CA)
Inventor: BOCKENSTEDT CRAIG ROBERT
IPC: A61N7/02
Filed: 2008-10-24
Abstract: An interchangeable transducer for use with an ultrasound medical system having a keyless adaptor and capable of operating in a wet environment. The interchangeable transducer has an adaptor for engaging a medical system, an ultrasound transducer and additional electronics to provide a self-contained insert for easy replacement and usage in a variety of medical applications.  A slip ring spacer is also disclosed, the slip ring spacer for use with a pancake slip ring having a base and flange configuration to form one or more channels around each contact ring of the pancake slip ring. The channels provide fluid isolation around each connector to help reduce electronic cross talk and contact corrosion between the connector pads of the slip ring while the slip ring is immersed in a wet environment.
Patent CA-2703973-A1 (CA)
Inventor: KIEN KATHRYN CHRISTIAN
IPC: B41M1/14
Filed: 2008-10-29
Abstract: An absorbent paper product comprising indicia wherein the indicia comprise L*a*b* color wherein the L*a*b* values are outside of the boundary described by the following system of equations (I) wherein L* is from 0 to 100.
Patent CA-2704527-A1 (CA)
Inventor: CAI YUPING ANTHONY
IPC: C07K16/18
Filed: 2008-10-29
Abstract: Monoclonal antibodies are provided that selectively bind human hepcidin-25 and are characterized as having high affinity for human hepcidin-25 and strong human mature hepcidin neutralizing properties. The antibodies of the invention are useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human and for the treatment and diagnosis of mature hepcidin-promoted disorders such as anemia, in a human subject.
Patent CA-2704708-A1 (CA)
Title: Placing water turbines in water flows
Inventor: FARB DANIEL
IPC: F03B13/22
Filed: 2008-11-30
Abstract: A floating turbine, including a vertical substantially fixed structure such as a pile or cable, a hydroelectric turbine, a connecting piece between the turbine and the structure that is operative to enable vertical motion of the turbine on the surface of the water.
Patent CA-2704766-A1 (CA)
Inventor: BEN-HORIN SHOMRON
IPC: A61M29/00
Filed: 2008-10-07
Abstract: Systems and methods for guidance of a gastrointestinal device through a gastrointestinal tract are provided. A gastrointestinal guidewire is positioned through the gastrointestinal tract, by introduction of an introducing element into the gastrointestinal tract. One end of the gastrointestinal guidewire is attached to the introducing element, and the other end of the gastrointestinal guidewire is attached to an anchoring element, anchored to a location outside of the gastrointestinal tract.  Movement of the introducing element through the gastrointestinal tract results in positioning of the guidewire through the gastrointestinal tract.  The guidewire is then used as a scaffold to guide the gastrointestinal device, wherein the gastrointestinal device may be externally controlled.  This allows for speeding up, slowing down, reversal and stopping of the gastrointestinal device during its descent through the gastrointestinal tract.
Patent CA-2706531-A1 (CA)
Title: Ion- ion reaction device
Inventor: BROWN JEFFERY MARK
IPC: H01J49/00
Filed: 2008-11-24
Abstract: An ion-ion reaction cell is provided comprising a plurality of electrodes (1) forming an ion guide ()2. A transient DC voltage wave is applied to the electrodes (2) in order to load reagent anions into the ion guide (2). Analyte cations are then subsequently transmitted through the ion-ion reaction cell by a subsequent transient DC voltage wave. Ion are arranged to undergo ion-ion reactions within the reaction cell and the resulting fragment ions which are formed within the reaction cell are then subsequently translated out of the reaction cell by means of a transient DC  voltage wave.
Patent CA-2709430-A1 (CA)
Inventor: KLEIN CHRISTIAN
IPC: C07K16/28
Filed: 2008-12-16
Abstract: The present invention relates to novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use.
Patent CA-2711187-A1 (CA)
Title: Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders
Inventor: SHLIEOUT GEORGE
IPC: A61K38/46
Filed: 2009-01-02
Abstract: The present invention relates to pharmaceutical compositions comprising granules containing at least one recombinantly produced purified microbial lipase, the use of said pharmaceutical compositions for the manufacture of a medicament for the prevention or treatment of certain diseases or disorders like pancreatic endocrine insufficiency, and a process for the manufacture of said pharmaceutical compositions.
Patent CA-2711384-A1 (CA)
Inventor: HOCEK MICHAL
IPC: C07H19/14
Filed: 2009-01-15
Abstract: The invention provides compounds of formula (I), wherein R1 and R2 have any of the values defined in the specification and salts thereof, as well as composi-tions comprising such compounds and therapeutic methods that utilize such compounds.
Patent CA-2711708-A1 (CA)
Inventor: BYSTROEM STYRBJOERN
IPC: A61P27/00
Filed: 2009-01-16
Abstract: The present invention relates to novel isoxazole compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers or N-oxides thereof, which are modulators of 11.beta.-hydroxysteroid dehydrogenase type 1(11.beta.-HSD1). The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the preparation of a medicament for the treatment of glaucoma.
Patent CA-2712394-A1 (CA)
Inventor: TERRY THEOPHILUS B III
IPC: C02F1/00
Filed: 2010-08-06
Abstract: A gas baffle for a waste water treatment plant filter housing that includes a first and second deflecting plate. The gas baffle has at least one flow-through opening defined by the first and second deflecting plates. The combination of the first and second deflecting plates deflects rising gas bubbles and any solid particulates so that the bubbles and particulates do not enter the filter housing. The gas baffle may include exterior apertures to dissipate the rising gas bubbles that travel on the bottom surface of each deflecting plate. The gas baffle may be integrally formed with the filter housing or created separately and subsequently connected.
Patent CA-2713081-A1 (CA)
Inventor: OLIVER PAHILA S
IPC: A62C35/68
Filed: 2009-02-13
Abstract: A fire protection method is provided that comprises providing at least one special application control mode extended coverage sprinkler for storage applications having a K-factor of at least 14 that is connectable to a piping network to protect commodity hazards including class one through four and cartoned unexpanded plastics, as defined in National Fire Protection Association Standard 13 and FM Global Property Loss Prevention Data Sheets 8-1 and 8-9, stored in a storage area defined by a storage height of at least 25 feet, and a building height of at least 30 feet, wherein the sprinkler provides coverage to an area of at least 144 square feet. The method also includes connecting the at least one sprinkler to the overhead piping network at a height at least equal to the storage height, activating the sprinkler in the event of a fire condition sensed by the sprinkler head, and delivering a fluid fed to the sprinkler to a coverage area of at least 144 square feet.
Patent CA-2713422-A1 (CA)
Title: Characterizing laminate shape
Inventor: PHARAND SYLVAIN
IPC: B07C5/12
Filed: 2010-09-09
Abstract: A method of sorting laminates includes characterizing first shapes of laminates from measurements taken of each, assembling the laminates to derive a first relationship between the first shapes and yield loss, characterizing second shapes of the laminates from a reduced number of the measurements to derive a second relationship between the second shapes and yield loss, analyzing a change in the derived relationships to determine a least number of the measurements necessary for achieving the yield loss and sorting supplied laminates in accordance with a characterized shape of each, which is obtained from the least number of the measurements taken for each supplied laminate.
Patent CA-2713517-A1 (CA)
Inventor: CHIAVERINI MICHAEL ANTHONY
IPC: A23L27/30
Filed: 2010-08-26
Abstract: In one embodiment, a method comprises selecting ingredients including a natural, high-intensity sweetener, a dairy milk or a non-dairy milk base, and one or more other ingredients selected from the group consisting of stabilizers, vitamins, minerals, flavors, functional ingredients, salts, antioxidants, sugar, and water. The selected ingredients are added to a mixing chamber and mixed to yield a formulation with the ingredients dispersed substantially evenly throughout.
Patent CA-2715802-A1 (CA)
Inventor: VASCONCELOS TEOFILO CARDOSO DE
IPC: A61K9/14
Filed: 2009-02-27
Abstract: A pharmaceutical composition containing a solid dispersion of a poorly soluble active pharmaceutical ingredient, an amorphous carrier and a surfactant.
Patent CA-2716676-A1 (CA)
Inventor: ASADA MASANORI
IPC: A61K31/702
Filed: 2009-03-02
Abstract: The present invention provides an inhibitor for blood phosphorus level elevation comprising a lactic acid bacterium as an active ingredient. The inhibitor for blood phosphorus level elevation of the present invention is highly safe, is readily administerable, and can sufficiently inhibit a blood phosphorus level elevation.
Patent CA-2717948-A1 (CA)
Inventor: GARCIA-ECHEVERRIA CARLOS
IPC: A61K45/06
Filed: 2009-03-24
Abstract: The invention relates to the use of compounds of formula (I) or (II) in the treatment of mammalian target of VEGF-driven angiogenic diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases.
Patent CA-2719352-A1 (CA)
Title: Procede ameliore de fabrication d'un disque aubage monobloc, avec anneau provisoire de maintien des aubes retire avant une etape de finition par fraisage
Inventor: BERLANGER SERGE
IPC: B23P13/02
Filed: 2009-03-25
Abstract: La présente invention se rapporte à un procédé de fabrication d'un disque aubagé monobloc, comprenant : - une étape de découpe par jet d'eau abrasif d'un bloc de matière, réalisée de manière à faire apparaître des préformes d'aubes s'étendant radialement à partir d'un disque (4), tout en conservant de la matière formant moyens de liaison (112) entre au moins deux préformes d'aubes directement consécutives; puis - une étape de fraisage des préformes d'aubes réalisée de manière à obtenir des ébauches d'aubes (202) mises à profil; puis - une étape de retrait desdits moyens de liaison (112); puis - une étape de finition par fraisage des ébauches d'aubes (202), de manière à obtenir les aubes (2) au profil final.
Patent CA-2727910-A1 (CA)
Inventor: FLEMING ALISTAIR IAN
IPC: A61B17/94
Filed: 2011-01-13
Abstract: A surgical retrieval apparatus includes an elongate tubular member having a drive rod slidably disposed therein. A support member is operably coupled to a distal end of the drive rod.  A pouch is attached to the support member and has a closed end and an open end. The pouch is securely coupled to the support member.
Patent CA-2729710-A1 (CA)
Inventor: GIANNINI GIUSEPPE
IPC: A61P25/00
Filed: 2009-06-30
Abstract: The present invention relates to formula I compounds having antitumoural activities through, as one possible biological target, the molecular chaperone heat shock protein 90 (Hsp90) inhibition. The invention includes the use of such compounds in medicine, in relation to cancer disease as well as other diseases where an inhibition of Hsp90 is responsive, and the pharmaceutical compositions containing such compounds.
Patent CA-2731118-A1 (CA)
Inventor: HAINES NORMAN GRAHAM
IPC: E02F9/28
Filed: 2009-07-20
Abstract: A wear part including an attachment box with a forwardly extending ground engaging blade member having an upper surface and an extension rib extending upwardly from one lateral side of the upper surface of the blade member and extending substantially parallel to the direction of ground engagement.
Patent CA-2738333-A1 (CA)
Inventor: HUMPHREYS LEN
IPC: C12P7/10
Filed: 2009-10-01
Abstract: The invention relates to methods for the conversion of lignocellulosic matter into fuel products. More specifically, the invention relates to methods for the generation of a bio-oil product from specific component(s) of lignocellulosic matter.
Patent CA-2739282-A1 (CA)
Inventor: MUNSON JAMES R
IPC: C11C3/10
Filed: 2009-10-02
Abstract: An economical and environmentally friendly, "green", process for the continuous purification of triacylglycerol (TAG) is described using a powdered, granulated or extruded adsorbent, which can be used in either the chemical or physical refining of edible oils and fats, both of which are traditionally used to refine TAG. The adsorbent is contained in a column system and is regenerated for reuse multiple times. The process utilizes the adsorbent column system as a treatment after chemical refining or before physical refining rather than water or filtration, respectively, to remove soaps and other impurities entrained in a crude triacylglycerol. In the chemical refining process, the crude degummed triacylglycerol (CDTAG) is first refined to remove FFA, forming a once refined triacylglycerol (ORTAG), and then contacted with an adsorbent packed into column(s) prior to deodorization.  In the physical refining process, the crude degummed triacylglycerol (CDTAG) is contacted with an adsorbent packed into column(s) prior to the removal of FFA and subsequent deodorization. The CDTAG or ORTAG is contacted with an adsorbent packed into a column, or multiple columns in series, for a sufficient amount of time to remove impurities such as, but not limited to, soaps, metals, chlorophyll, and many of the other compounds that reduce the stability of the TAG. The resulting TAG exiting the column(s) is ready for the deodorization process. Once the adsorbent no longer removes the desired amount of impurities, it is regenerated for reuse. Such a continuous regenerable adsorbent refining process substantially reduces the amount of fresh water required and the amount of waste water generated to purify TAG and reduces the amount of solid waste produced. The result is a cost effective and environmentally friendly edible oil refining process.
Patent CA-2740831-A1 (CA)
Title: Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation
Inventor: BOLDUC LEE
IPC: A61F2/82
Filed: 2009-10-14
Abstract: Devices, systems, and methods for implanting expandable prostheses in the body lumens rely on stapling or anchoring the prostheses with separately introduced fasteners. The prostheses may be self -expanding or balloon expandable, and may include a single lumen or more than one lumen. After initial placement, a stapling system is introduced within the expanded prosthesis to deploy a plurality of fasteners to at least one prosthesis end. The stapling system may apply a force- to the prosthesis to modify the shape of the prosthesis to conform to the shape of the vessel wall. The stapling system can be deflected in one or more distinct steerable segments. A lumen extension or lumens may be coupled to the prosthesis to extend the reach of the prosthesis within the implantation site. Fasteners may also be applied to the lumen extensions.
Patent CA-2741815-A1 (CA)
Inventor: KOEPPEN CARSTEN
IPC: H02J9/06
Filed: 2009-11-10
Abstract: The present invention provides a power distribution device for distributing power and a method for the distribution of power.   The power distribution device for distributing power, in particular in an aircraft, has a number, N1, of conversion devices comprising a respective cascade generator for converting a first part of a mechanical power provided into a first electrical power with an alternating voltage of constant amplitude and constant frequency, and comprising a respective frequency converter for supplying a second electrical power with the alternating voltage of constant amplitude and constant frequency as a function of a second part of the mechanical power provided; a number N2 of constant frequency buses for the respective transfer of the electrical power of constant frequency supplied by the at least one conversion device to a number N3 of loads which comprises at least a number N4 of loads to be controlled in terms of their power consumption; and a number N4 of control devices, wherein the respective control device is coupled between the respective load to be controlled and the constant frequency bus and is designed to control the power consumption of the load to be controlled.